ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
ISPOR Membership: Becoming an ISPOR member offers unique advantages in health economics and outcomes research (HEOR). Members gain valuable benefits, global networking opportunities, and platforms for advancing HEOR excellence, joining nearly 18,000 professionals across 100+ countries who are dedicated to improving healthcare decision making worldwide. https://www.ispor.org/membership
HEOR Learning Lab™ is ISPOR’s on-demand educational resource, offering unlimited video content from conferences and events. Covering key topics like real-world evidence, digital health, AI, and health policy, it supports continuous learning for HEOR professionals and interested learners worldwide. https://www.ispor.org/welcome-HEOR-Learning-Lab
ISPOR VIDEOS
-
![Top HEOR Trends]( "ISPOR Top 10 HEOR Trends: What Are The Key Themes For 2026-27?")
Healthcare decision-making is evolving fast. Discover how AI, RWE, and changing HTA frameworks are influencing pricing, patient engagement, and market access.
-
![Dive Into Core Topic Areas Of The HEOR field]( "Dive Into Core Topic Areas Of The HEOR field")
Join us to see how HEOR drives impact across the global healthcare landscape.
-
![Challenges And The Role Of HEOR]( "Patient Centered Research: Challenges And The Role Of HEOR")
How can research better reflect patient needs? Explore expert perspectives on Patient-Centered Research and the growing role of HEOR in decision-making.
-
![Leveraging AI In HEOR Innovation In Evidence And Outcomes]( "Leveraging AI In HEOR: Innovation In Evidence And Outcomes")
Stay at the forefront of digital innovation in healthcare and understand how artificial intelligence is revolutionizing Health Economics and Outcomes Research (HEOR) in this insightful video.
-
![Whole Health In Action Real-World Examples Of Better Outcomes]( "Whole Health In Action: Real-World Examples Of Better Outcomes")
Whole health looks beyond traditional care by addressing food access, environment, and lived experiences—leading to healthier communities and more holistic outcomes.
-
![Health Economics And Outcomes Research]( "Health Economics And Outcomes Research (HEOR) Explained")
Learn about this accessible way to understand what HEOR is, how it’s used, and its impact on people and healthcare systems.
-
![Drug Price Controls]( "Drug Price Controls: What Are The Unintended Consequences To Innovation?")
Review the ripple effects of drug price controls, including recent U.S. policy shifts like the IRA and President Trump’s Executive Order introducing International Reference Pricing.
CONTACT INFORMATION
ISPOR—The Professional Society for Health Economics and Outcomes Research
505 Lawrence Square Blvd South
Lawrenceville, NJ 08648
UNITED STATES
Phone: (609) 691-8942
Contact: Michelle Rovner
FEATURED ARTICLES
-
![regulatory-healthcare-GettyImages-600698208]( "Beyond Healthcare Spending: The Evolving Definition Of Value In Health Policy")
As pharmaceutical policy takes on more goals, success is harder to define. Value extends beyond spending, requiring evidence that expected benefits are realized.
-
![clinical-regulation-GettyImages-1423366794]( "US Healthcare System Overview")
A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.
-
![top-10-trends-GettyImages-2231462868]( "Top 10 HEOR Trends Report")
Emerging trends in HEOR reveal how AI, real‑world evidence, value‑based care, digital health, and evolving affordability pressures are reshaping global healthcare.
-
![trumprx_policy_GettyImages-2215852206]( "Policy To Practice: PBM Reform, TrumpRx, And Global Drug Development")
Policy shifts are reshaping PBM oversight, driving transparent drug‑pricing tools, and influencing global responses that affect affordability, access, and future pharma development.
-
![clinical-policies-GettyImages-1968804430]( "Key Health Policy Priorities Shaping The Second Half Of 2026")
See late‑2025 policy actions, including international pricing agreements, new payment models, and global regulatory changes, while previewing key themes expected to shape 2026 health policy.
-
![trends-clinical-GettyImages-1386103571]( "5 Trends To Watch This Year")
Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.
-
![Ispor CEO]( "Hope In The Dark: Value In Alzheimer's Disease Research And Treatment")
The May/June 2025 issue of Value & Outcomes Spotlight explores the health economics and outcomes research (HEOR) and its contribution to research and treatment of Alzheimer’s disease.
-
![rob-abbott]( "Enhancing The Accessibility And Affordability Of Healthcare")
The March/April 2025 issue of Value & Outcomes Spotlight explores the urgent global health crisis of accessibility and affordability, highlighting the nearly 2 billion individuals lacking essential medicines.
-
![GettyImages-1416816620 medical records, RWE]( "Top HEOR Trends")
Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.
-
![GettyImages-944464752 research, teamwork, collaboration]( "ISPOR 2024-2025 Top 10 HEOR Trends")
This report outlines ten defining HEOR trends influencing global health decision-making.
-
![GettyImages-1293438556-document-computer-check-mark-magnifying-glass]( "HEOR In Action")
Health Economics and Outcomes Research (HEOR) plays a vital role in guiding evidence-based decisions across the healthcare ecosystem.
